SCIENTIFIC HUB

Follow the evidence.

106.213 articles found

Open access

Are glutathionylated aldehyde reductases the missing piece of the "catecholaldehyde hypothesis" in Parkinson's disease? A medical hypothesis concerning the detoxification of 4-hydroxynonenal (HNE) and 3,4-dihydroxyphenylacetaldehyde (DOPAL).

Rotondo R, Russo M, Iacovelli F, Calabrese V, de Iure A, Gaglione M, Leonardi L, Cocorocchia G, Stocchi F, Stocchi V, de Pandis MF, Picconi B.

Redox Biol · 2026-01-27

DOI: 10.1016/j.redox.2026.104060PMID: 41637878

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Long-term outcomes associated with istradefylline versus catechol-O-methyltransferase inhibitors in patients with Parkinson's disease: a nationwide real-world cohort study.

Ju C, Kubota K, Xiong X, Sato T, Carroll C, Schrag A, Wei L, Foltynie T.

Parkinsonism Relat Disord · 2026-01-27

DOI: 10.1016/j.parkreldis.2026.108211PMID: 41637901

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.